“Alector is an immuno-neurology focused biotech start-up advancing first-in-class therapeutics for neurodegenerative disorders like Alzheimer’s disease. In collaboration with Biomedcode we explored the potential application of some of our drugs in the area of bone disease. We took advantage of their newly generated transgenic mouse model. They provided us with an excellent study report, with detailed explanations. Communication was very smooth and discussions were always very exhaustive. Overall it was a productive collaboration.”